Skip to main content

Table 2 Serial sperm parameters and virological analyses in subjects suffering from COVID-19

From: Mild COVID-19 has no detrimental effect on semen quality

 

First sample

Second sample

Third sample

p-value

Effect size

n

23

23

23

  

Semen volume (ml)

2.8 (2.5–3.9)

2.6 (1.8–2.9)

3.0 (1.9–3.6)

0.617a

0.021c

Sperm concentration (106/ml)

46.0 (25.0–86.0)

32.0 (12.0–78.0)

48.0 (26.0–68.0)

0.435a

0.036c

Total sperm number (106/ejaculate)

150.0 (79.2–232.5)

97.2 (28.0–176.4)

101.4 (45.6–166.6)

0.062a

0.121c

Progressive motility (%)

25.0 (15.0–35.0)

20.0 (15.0–40.0)

30.0 (15.0–45.0)

0.220a

0.066c

Total motility (%)

40.0 (20.0–40.0)

30.0 (20.0–50.0)

40.0 (20.0–55.0)

0.144a

0.084c

Normozoospermia (n)

9 (39.1%)

9 (39.1%)

9 (39.1%)

 > 0.999a

0.00b

Time of abstinence (days)

4 (3.0–6.0)

3 (3.0–4.0)

4 (2.0–5.0)

0.054a

0.127c

SARS CoV-2-positive PCR of ejaculates (n)

0

0

0

  

SARS-CoV-2-positive cell cultures of ejaculates (n)

0

0

0

  
  1. Continuous data are presented as the median (Q1–Q3; Q1 = 25th percentile and Q3 = 75th percentile) and categorical data as frequencies (%)
  2. aFriedman test
  3. bCochrane’s Q test
  4. cKendall’s W